Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China.
Cancer Rep (Hoboken). 2024 Sep;7(9):e2165. doi: 10.1002/cnr2.2165.
Surgical resection is the primary treatment option for patients diagnosed with nonfunctional pancreatic neuroendocrine tumors (NF-Pan-NETs). However, the postoperative prognostic evaluation for NF-Pan-NET patients remains obscure. This study aimed to construct an efficient model to predict the prognosis of NF-Pan-NET patients who have received surgical resection.
NF-Pan-NET patients after pancreatectomy were retrieved from the SEER database for the period of 2010 to 2019. A total of 2844 patients with NF-Pan-NET from SEER database were included in our study. After careful screening, six clinicopathological variables including age, grade, AJCC T stage, AJCC N stage, AJCC M stage, and chemotherapy were selected to develop nomograms to predict overall survival (OS) and cancer-specific survival (CSS) respectively of the patients.
The novel models demonstrated high accuracy and discrimination in prognosticating resected NF-Pan-NET through various validation methods. Furthermore, the risk subgroups classified by the newly developed risk stratification systems based on the nomograms exhibited significant differences in both OS and CSS, surpassing the efficacy of the AJCC 8th TNM staging system. Novel nomograms and corresponding risk classification systems were developed to predict OS and CSS in patients with NF-Pan-NET after pancreatectomy.
The models demonstrated superior performance compared to traditional staging systems, providing clinicians with more accurate and personalized guidance for postoperative surveillance and treatment.
手术切除是非功能性胰腺神经内分泌肿瘤(NF-Pan-NET)患者的主要治疗选择。然而,NF-Pan-NET 患者术后的预后评估仍然不清楚。本研究旨在构建一种有效的模型,以预测接受手术切除的 NF-Pan-NET 患者的预后。
从 SEER 数据库中检索 2010 年至 2019 年接受胰切除术的 NF-Pan-NET 患者。我们的研究共纳入了来自 SEER 数据库的 2844 例 NF-Pan-NET 患者。经过仔细筛选,选择了 6 个临床病理变量,包括年龄、分级、AJCC T 分期、AJCC N 分期、AJCC M 分期和化疗,分别建立列线图来预测患者的总生存率(OS)和癌症特异性生存率(CSS)。
通过各种验证方法,新模型在预测切除后的 NF-Pan-NET 预后方面表现出了较高的准确性和区分度。此外,基于列线图新开发的风险分层系统将患者分为不同的风险亚组,在 OS 和 CSS 方面均表现出显著差异,优于 AJCC 第 8 版 TNM 分期系统的疗效。本研究建立了预测 NF-Pan-NET 患者胰切除术后 OS 和 CSS 的新列线图和相应的风险分类系统。
与传统的分期系统相比,该模型表现出了更好的性能,为临床医生提供了更准确和个性化的术后监测和治疗指导。